IMO the SP of this company should be at $0.70+ based on increase traction of revenues each quarter in the US. I guess there is a worry about the cash burn and cash held.
I really hope that a takeover does not come now at say $0.90 which is a 100%+ premium to current SP as it will undersell all the work the company has achieved over the years.
This happened at Viralytics where the SP was beaten down to $0.615 even after a Chinese medical company took a stake at $0.80 before Merck lobbed a takeover at $1.75.
IMO the SP of this company should be at $0.70+ based on increase...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.684M | |||
| Open | High | Low | Value | Volume |
| 0.1¢ | 0.1¢ | 0.1¢ | $21.3K | 21.3M |
| AXP (ASX) Chart |